Australia markets open in 6 hours 30 minutes

iRhythm Technologies, Inc. (IRTC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
86.18-3.77 (-4.20%)
As of 11:30AM EST. Market open.

iRhythm Technologies, Inc.

699 8th Street
Suite 600
San Francisco, CA 94103
United States
415 632 5700
https://www.irhythmtech.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees1,793

Key executives

NameTitlePayExercisedYear born
Mr. Quentin S. BlackfordPresident, CEO & Director2.15MN/A1979
Mr. Brice Bobzien CPAChief Financial Officer685.12kN/A1979
Dr. Minang P. Turakhia M.D., M.S.Chief Medical & Scientific Officer and Executive VP of Product Innovation1MN/A1974
Mr. Patrick Michael Murphy J.D.Chief Business & Legal Officer1.28MN/A1979
Mr. Douglas J. DevineExecutive Advisor800kN/A1970
Mr. Chad M. PattersonChief Commercial Officer771.51kN/A1982
Mr. Marc RosenbaumSenior VP of Finance & Chief Accounting OfficerN/AN/A1972
Mr. Mark J. Day Ph.D.Chief Technology Officer718.76k1.28M1971
Mr. Daniel G. WilsonExecutive VP of Corporate Development & Investor Relations670.09kN/A1983
Ms. Sumi ShrishrimalExecutive VP & Chief Risk OfficerN/AN/A1979
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Corporate governance

iRhythm Technologies, Inc.’s ISS governance QualityScore as of 1 December 2023 is 7. The pillar scores are Audit: 10; Board: 5; Shareholder rights: 6; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.